Ventilator-Associated Pneumonia research hub
4 indexed studies · 3 currently recruiting
- authorisedPhase I and Phase II (Integrated)- First administration to humans
A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia
This study is testing a new treatment called TP-122 for a serious lung infection called ventilator-associated pneumonia. Researchers want to see if it's safe, how well people tolerate it, and if it helps patients get better faster when added to standard care.
Portugal · Netherlands - recruiting
Inspiratory Work of Breathing Before and After Extubation
This study looks at how breathing is affected in lung transplant patients on breathing machines, both before and after the machine is removed. It uses new tools to measure lung function and breathing effort to find the best way for patients to come off breathing support.
Canada - recruiting
Early Severe Illness TrAnslational BioLogy InformaticS in Humans
This study, called ESTABLISH, looks at how the body reacts to severe illnesses like sepsis in the Intensive Care Unit (ICU). Researchers want to find better ways to diagnose these conditions early and discover new treatments to help patients recover.
Canada - recruitingPHASE3
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
This study is testing if an antiviral medicine, acyclovir, helps seriously ill patients in intensive care with pneumonia and the herpes simplex virus (which causes cold sores). We want to find out if treating this virus improves their chances of recovery.
Germany